Yuliang Zhao, PhD

  • 38264 Citations
  • 103 h-Index
19962020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Personal profile

Dr. Yuliang Zhao earned his Ph.D. in Chemical Science from the Tokyo Metropolitan University in 1999. He held faculty appointments at the Chinese Academy of Sciences in Beijing before becoming a member of Houston Methodist Research Institute in 2011. Dr. Zhao also holds adjunct faculty appointments at Peking University (Beijing), the Medical School of Jilin University (Changchun), and Sichuan University (Chengdu).

As the the founder and Director of CAS Key Lab for Biomedical Effects of Nanomaterials & Nanosafety, he directs a research program that is developing a new generation of cancer chemotherapeutics using low-toxic nanoparticles. Dr. Zhao has also been a member of nine study sections and review boards in China and Europe. He is the founder and Director of Research Center for Cancer Nanotechnology at Tianjin Cancer Hospital in China. He has served as the Associate Editor and editorial board member of seven scientific research journals since 2006.

Research interests

Dr. Zhao's research program focuses on nanotoxicology, cancer nanotechnology, and nanochemistry. He is developing molecular dynamics modeling for designing low-toxic nanosurfaces for cancer nanotechnology applications, and for lowering the toxicity of nanomaterials in living systems. A major aim of his research is to understand the mechanisms of nanotoxicity of engineered nanoparticles in vivo. In addition, a major research goal is to characterize the structure-function relationships between the tumor microenvironment (like extracellular matrices) and engineered nanoparticles that inhibit tumor growth and metastasis. Dr. Zhao's research team at CAS collaborates with Dr. Mauro Ferrari, Dr. Ye "Tony" Hu and other faculty members of the Department of Nanomedicine at the Research Institute in the research of cancer nanotechnology and nanotechnology based biomarker identification.

Education/Academic qualification

Chemistry, Postdoctoral Fellowship, Japan Society for the Promotion of Science, Tokyo Metropolitan University, Tokyo

PhD, Tokyo Metropolitan University

External positions

Chinese Academy of Sciences, Center for Excellence in Nanoscience

Free-text keywords

  • Nanotoxicology
  • Cancer nanotechnology
  • Chemistry
  • Nanoscale molecular dynamics modeling

Research Area Keywords

  • Nanomedicine

Fingerprint Dive into the research topics where Yuliang Zhao is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

15 Years of Small: Research Trends in Nanosafety

Zhu, S., Li, L., Gu, Z., Chen, C. & Zhao, Y., Sep 1 2020, In : Small. 16, 36, 2000980.

Research output: Contribution to journalArticle

  • 1 Scopus citations

    A Heterojunction Structured WO2.9-WSe2Nanoradiosensitizer Increases Local Tumor Ablation and Checkpoint Blockade Immunotherapy upon Low Radiation Dose

    Dong, X., Dong, X., Cheng, R., Cheng, R., Zhu, S., Liu, H., Liu, H., Zhou, R., Zhou, R., Zhang, C., Zhang, C., Chen, K., Chen, K., Mei, L., Mei, L., Wang, C., Wang, C., Su, C., Liu, X., Gu, Z. & 3 others, Gu, Z., Zhao, Y. & Zhao, Y., May 26 2020, In : ACS Nano. 14, 5, p. 5400-5416 17 p.

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    Cell-Penetrating Nanoparticles Activate the Inflammasome to Enhance Antibody Production by Targeting Microtubule-Associated Protein 1-Light Chain 3 for Degradation

    Zhu, M., Du, L., Zhao, R., Wang, H. Y., Zhao, Y., Nie, G. & Wang, R. F., Mar 24 2020, In : ACS Nano. 14, 3, p. 3703-3717 15 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Nano-bio interactions: the implication of size-dependent biological effects of nanomaterials

    Wang, X., Cui, X., Zhao, Y. & Chen, C., Jan 1 2020, In : Science China Life Sciences.

    Research output: Contribution to journalReview article

  • 1 Scopus citations

    Nd3+-Sensitized Upconversion Metal–Organic Frameworks for Mitochondria-Targeted Amplified Photodynamic Therapy

    Liu, C., Liu, B., Zhao, J., Di, Z., Chen, D., Gu, Z., Li, L. & Zhao, Y., Feb 10 2020, In : Angewandte Chemie - International Edition. 59, 7, p. 2634-2638 5 p.

    Research output: Contribution to journalArticle

  • 10 Scopus citations